Biotherapy Plus

Biotherapy Plus
Biotherapy Plus
Developer: ERRAFIOS
Category: Medical
1.7K installs
Ratings not yet available
69 monthly active users
Revenue not available
Install Trends
Weekly +3.00
Declining
Monthly +12
Declining

Biotherapy Plus Summary

Biotherapy Plus is a mobile Android app in Medical by ERRAFIOS. Released in Feb 2020 (6 years ago). It has about 1.7K+ installs Based on AppGoblin estimates, it reaches roughly 69 monthly active users . Store metadata: updated Apr 27, 2025.

Recent activity: 3.00 installs this week (12 over 4 weeks) showing declining growth View trends →

Store info: Last updated on Google Play on Apr 27, 2025 .


0★

Ratings: 0

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

Biopharmaceuticals Handbook for Healthcare Professionals

Practical Medical Manual of Biomedicines
Used in the Treatment of Autoimmune Diseases and Certain Hemopathies
This edition is intended for medical and paramedical personnel.

+Features:
-Content available offline.
-A very simple, practical, and free application.
-Covers the main molecules and active ingredients.
-Quick search functionality (by substance name or trade name).
-Necessary assessments before initiating biotherapy.
-Presentations, formulations, premedication, dosage, and administration rates of biotherapies.
-Availability, pricing, and reimbursement details (Morocco).
-Monitoring guidelines: tolerance, efficacy, and time to therapeutic response.
-Practical scenarios: management in cases of trauma, burns, dental procedures, pregnancy, or breastfeeding.
-Bibliographical references for each molecule (internet connection required).

+List of Included Molecules:
-Anti-TNF: Infliximab, Etanercept, Adalimumab, Golimumab, Certolizumab Pegol…
-Anti-CD28: Abatacept
-Anti-IL1: Anakinra, Canakinumab…
-Anti-IL6: Tocilizumab, Sarilumab, Siltuximab…
-Anti-IL12/IL23: Ustekinumab
-Anti-IL17: Secukinumab, Brodalumab, Ixekizumab…
-Anti-CD20: Rituximab
-Anti-RANK Ligand: Denosumab
-Anti-BLyS: Belimumab
-Anti-JAK: Tofacitinib, Baricitinib, Ruxolitinib, Upadacitinib, Filgotinib…

**** By installing this application, you automatically agree to the terms and rules of use:
1 - Purpose and Nature of the Application
The application is a free practical guide intended for professionals and students in the medical and paramedical fields, specializing in the use of biopharmaceuticals.

2 - Disclaimer
A - Content and Accuracy of Information
The content of the application comes from various sources (see "References" section). The author disclaims any liability for unintentional errors, whether arising from an external source, a typographical mistake, or a misinterpretation.
B - Material and Non-Material Damages
The author cannot be held responsible for any direct or indirect damages, whether material or immaterial, caused to the user’s device due to the installation or use of the application.
C - Modifications and Updates
The author reserves the right to modify, update, or remove the content of the application at any time, without prior notice.

3 - Intellectual Property
Any reproduction, distribution, or use of the content of this application is prohibited without the express authorization of the author. The logo and the title "Biothérapie Plus ©" are protected under the provisions of the Intellectual Property Code.

4 - Collection of Personal Data by the Application
The author declares that no mechanism for collecting user data has been integrated into or included in the application’s source code, which has been verified in accordance with Google Play® security protocols.

Information:
• The addition of new sections and molecules is planned for future updates.
• Indications, dosages, administration rates, and therapeutic response categories are currently available mainly for rheumatology. Additional information will be added regularly.
• Do not hesitate to contact us with any concerns or suggestions.

Written content and application engine developed by Pr. Souhil Errafia, Professor of Rheumatology, Faculty of Medicine and Pharmacy, Beni Mellal.